JANET KIM: Open Payments
NPI 1902584733 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 9 payments from 6 companies in 2025. Trend: 2023 $110 · 2024 $735 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 3 | $81 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Phathom Pharmaceuticals, Inc. | 1 | $34 |
| Gilead Sciences, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: Orserdu, KISQALI, VOQUEZNA, Trodelvy, Enhertu, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
